Request Trial
amelia19-shutterstock-com
Amelia19 / Shutterstock.com
4 June 2015EuropePaul England and Anja Lunze

UPC: The true meaning of opt-out

Our previous article discussed which type of patent can be litigated where in the new Unified Patent Court (UPC) system. This included the dual track—national and UPC—jurisdiction for classical European patents that will operate during the transitional period.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents
12 February 2026   The court has denied a German non-practising entity’s bid to secure unitary protection for a patent that it has asserted against Intel.
Europe
Reaction: Emotional Perception decision is ‘good for UK PLC’
12 February 2026   UK and European patent attorneys share their initial views after the UK Supreme Court delivered its landmark judgment, which “brings some much‑needed clarity and consistency” to the patentability of AI-related innovations—including those in the medtech industry.
Europe
UK ruling ‘future-proofs’ patentability for AI and computer tech
12 February 2026   The patent community rejoices after the UK Supreme Court's Emotional Perception decision aligns the UK with Europe, paving the way for computer tech companies to protect inventions—including those in the medtech industry.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

More features

UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents
Reaction: Emotional Perception decision is ‘good for UK PLC’
UK ruling ‘future-proofs’ patentability for AI and computer tech
The curtain closes on three major drug disputes
Novartis takes aim at Tafinlar generic in latest suit
INTA: ‘Davos of IP’ will take London meeting to a ‘different level’
Squire Patton Boggs brings in tech and data expert as Ireland practice lead
Drowning in EU regulations? Five tips for surviving the deluge of new rules